← FDA DRUG APPROVALS

FDA ANDA · ANDA209467

SUCCINYLCHOLINE CHLORIDE

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA209467
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-04
LATEST ACTION
2022-02-09
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SUCCINYLCHOLINE CHLORIDEPrescription
SUCCINYLCHOLINE CHLORIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2022-02-09Labeling · Supplement 7 · standardAP
2021-03-04Labeling · Supplement 5 · standardAP
2020-04-06Labeling · Supplement 2 · standardAP
2018-05-04UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →